Membrana

Charlotte, United States Founded: 1998 • Age: 28 yrs Acquired By 3M
Microporous filtration membranes are produced for life sciences uses.

About Membrana

Membrana is a Healthcare company based in Charlotte (United States) founded in 1998, and was acquired by 3M in February 2015. Microporous filtration membranes are produced for life sciences uses. Its chief executive, as recorded, is Mike Roman. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Filtration. Its competitors include Cytosorbents, TeraPore and Alkymos; 3 of its 3 listed competitors have raised funding.

Company details

Membrana was founded in 1998 and is based in Charlotte, United States. Operations center on the production of microporous membranes used in life sciences sectors, including hemodialysis, blood oxygenation, and plasmapheresis. These membranes facilitate the removal of sub-micron particulates from fluids and enable gasification or degasification processes in liquids. Applications extend to high-performance microfiltration, ultrafiltration, and related techniques.

  • Headquarters Charlotte, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Website membrana.com
  • Social LinkedIn
  • Acquired by 3M (Feb 2015)
Key Metrics

Investors in Membrana

Membrana has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include 3M.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
3M is recognized as a global leader in industrial innovation.
19023m.comUnited States
Premium access

Investor details for Membrana

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Membrana

1 people are tracked at Membrana (1 in leadership).

NameRoleGroup
Mike Roman
CEOLeadership
Premium access

Complete people profiles for Membrana

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Membrana

2 dated milestones of Membrana across 17 years, from founding to its latest funding, stage changes and deals.

  1. Founded Membrana is founded.
  2. Exit Acquired by 3M.

Competitors of Membrana

Membrana has 3 listed competitors in our database, 3 of them funded. They include Cytosorbents, TeraPore and Alkymos.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cytosorbents.com1997Monmouth Junction, United States$22.04M198
Hemoperfusion technology is developed to remove toxins from blood.
terapore.com2013San Francisco, United States$19.53M16
Developer of bioseparation solutions for therapeutics and novel biologics
alkymos.com2006Lexington, United States$643,500
Specializes in chelators and chelator-based filtration devices.
Premium access

Detailed competitors of Membrana

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Membrana (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Membrana

Premium access

Complete news archive for Membrana

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Membrana

Membrana was founded in 1998.

Membrana is headquartered in Charlotte, United States. It is registered at Charlotte, North Carolina, United States.

Mike Roman is the CEO of Membrana, as recorded in our data.

Membrana was founded in 1998 and is based in Charlotte, United States. Operations center on the production of microporous membranes used in life sciences sectors, including hemodialysis, blood oxygenation, and plasmapheresis. These membranes facilitate the removal of sub-micron particulates from fluids and enable gasification or degasification processes in liquids. Applications extend to high-performance microfiltration, ultrafiltration, and related techniques.

Membrana's top competitors include Cytosorbents, TeraPore and Alkymos.

Membrana has 1 investor. Key investors include 3M.

Yes. Membrana was acquired by 3M in February 2015.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available